Epilepsy News

News

Surgery for drug-resistant epilepsy may improve quality of life

20230518060000

Undergoing epilepsy surgery appears to yield clinically meaningful gains in quality of life (QoL), according to the results of a meta-analysis.

CBD yields comparable benefits in kids, adults with Lennox-Gastaut and Dravet syndrome

Jairia Dela Cruz, 20230517140000

Children with Lennox-Gastaut syndrome (LGS) and Dravet's syndrome (DS) achieve improvements in both seizure management and nonseizure outcomes following treatment with cannabidiol (CBD)—a success echoed in their adult counterparts, as shown in a study presented at AAN 2023.

Implantable cardiac monitor shows promise for automated seizure detection

Jairia Dela Cruz, 20230508140000

A subcutaneously implanted cardiac monitor device, which incorporates an algorithm designed based on heart rate variability (HRV), may accurately detect focal seizures in individuals with ictal autonomic changes.

Perampanel for idiopathic generalized epilepsy passes muster in real world

20230505180000

Perampanel appears to be effective and have good tolerability in patients with idiopathic generalized epilepsy treated in everyday clinical practice settings, as shown in a study.

Does listening to classical music help in epilepsy?

20230316060000

For individuals with epilepsy, listening to classical music, specifically Mozart’s sonata, does not appear to provide any form of relief, according to the results of a meta-analysis.

Deep-brain stimulation affords greater seizure reduction than vagus nerve stimulation

20230309110000

Among the neurostimulation devices used in the treatment of generalized epilepsy, deep-brain stimulation performs better than vagus nerve stimulation at reducing seizure frequency, as reported in a study. On the other hand, while results for responsive neurostimulation are promising, further research is needed.

Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy

20230127100000

Patients with treatment-resistant epilepsy appear to benefit from add-on cannabidiol, which a recent study has shown to help reduce seizure frequency for up to 192 weeks.

Modified Atkins diet helps control drug-resistant epilepsy

Jairia Dela Cruz, 20230112090000

Teen and adult patients with drug-resistant epilepsy may benefit from modified Atkins diet, which has been shown in a recent study to produce improvements in seizure frequency, quality of life (QOL), and behavioural problems as compared with standard drug therapy.

Study reinforces guideline to avoid prescribing EIASMs in glioma patients with epilepsy

20221217140000

First-line monotherapy with levetiracetam appears to have a more favourable effectiveness than enzyme-inducing antiseizure medications (EIASMs) in glioma patients with epilepsy, owing to lower treatment failure for any reason and better tolerability, according to a study, which supports the current neuro-oncology recommendations to avoid EIASMs in this population.

Food interrupts absorption of diazepam nasal spray

20221215180000

Food appears to affect the pharmacokinetics of diazepam dosed via nasal spray, with absorption being markedly decreased and delayed, according to an open-label crossover study.

Long COVID: What we have learned so far

Prof. Ghassan Dbaibo, 27 Apr 2023

The WHO defines long COVID as a condition that occurs 3 months from COVID-19 onset, whose symptoms last ≥2 months and cannot be attributed to an alternative diagnosis. In an interview with MIMS Doctor, Professor Ghassan Dbaibo of the Center for Infectious Diseases, American University of Beirut, Beirut, Lebanon, describes the evolving attitudes towards long COVID among healthcare professionals (HCPs), some unexpected predisposing factors, potential biological mechanisms behind prolonged symptom duration and shares data on vaccination’s protective effects against long COVID.

Product Highlight - Pontevia

16 Mar 2022

Galcanezumab Injection